December 9, 2009
Beijing, China – China-based CSOFT International, Inc., a leading provider of multilingual localization, testing, and outsourced software development for the global market, announced today the hiring of Tammy Werner as Director of CSOFT’s MedL10N Business Unit and Manager of Business Development for the U.S., South East.
“Tammy’s management background in technical writing for life sciences is invaluable,” said Shunee Yee, CSOFT President and CEO. “With Tammy on board directing our MedL1ON division, we will have the infrastructure in place to further improve our localization solutions that specifically target the particular needs of our clients in the Life Sciences industry, while ensuring that every step of our process is focused on quality, compliance, and risk minimalization—all under the most effective leadership possible in a heavily regulated industry.”
Before joining MedL10N, Werner was the Manager of Technical Communications at the multi-billion dollar manufacturer of biomedical instruments, Beckman Coulter. In her role at Beckman Coulter, Werner managed the production and localization of all instrument manuals, as well as consumable labeling for Beckman Coulter’s production center in Miami. Key accomplishments under her leadership include streamlining the development of technical documents to reduce production time and costs, and galvanizing her division to be the first to publish all customer manuals in required languages online. This second accomplishment led to an annual savings of $500,000 USD in distribution costs, refined export operations, and improved customer satisfaction. Werner joined Beckman nearly 15 years ago, starting on a nine-week contract as a technical writer.
CSOFT provides a broad range of language and technology solutions in over 90 languages across a variety of industries, including IT, Life Sciences, Manufacturing, Automotive and Financial Services. CSOFT has one of the largest technical resources in Asia with operations spanning the U.S., China, Japan, Germany, Canada, the United Kingdom and Australia.
Please click here for more information on MedL10N.
About CSOFT Health Sciences
CSOFT Health Sciences, leaders in clinical trial localization, provides AI/ML-enabled medical translation services for all phases of the drug and medical device product lifecycle, from development to post-launch. We also specialize in DCT solutions, linguistic validation, and CTD/eCTD submissions with the FDA, EMA, and NMPA. Our operations are certified in ISO 17100:2015, ISO 9001:2015, and ISO 13485:2016, ensuring our customized solutions meet the rigorous regulatory requirements of MMA, NDA, CTA, and Medical Device Application submissions. www.csoftintl.com